| Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study (NCT00263705) | Jules Bordet Institute | 2003-01-01 |
| Protocol for Women at Increased Risk of Developing Breast Cancer (NCT00291135) | Carol Fabian, MD | 2003-01-01 |
| Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage (NCT00156260) | University of Michigan Rogel Cancer Center | 2003-01-01 |
| CP-724,714 in Treating Patients With Metastatic Breast Cancer (NCT00055926) | Jonsson Comprehensive Cancer Center | 2003-01-01 |
| Danish Breast Cancer Group Internal Mammary Node Study (NCT06549920) | Danish Breast Cancer Cooperative Group | 2003-01-01 |
| 3-Dimensional Form and Soft Tissue Biomechanics of the Breast (NCT00502814) | M.D. Anderson Cancer Center | 2003-01-01 |
| Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women (NCT00056082) | University of Kansas Medical Center | 2003-01-01 |
| Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer (NCT00206414) | Baylor Breast Care Center | 2003-01-01 |
| Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast Cancer (NCT01215162) | Mayo Clinic | 2003-01-01 |
| Predictors of Lymphedema Following Breast Cancer Surgery (NCT00202046) | HealthPartners Institute | 2003-01-01 |
| An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg (NCT00291109) | University of Kansas | 2003-01-01 |
| An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer (NCT00291122) | University of Kansas | 2003-01-01 |
| Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy (NCT00053898) | NSABP Foundation Inc | 2003-01-01 |
| A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) (NCT00725374) | Organon and Co | 2002-12-15 |
| Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients (NCT01823549) | Ohio State University Comprehensive Cancer Center | 2002-12-11 |
| Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ (NCT00290654) | Masonic Cancer Center, University of Minnesota | 2002-12-01 |
| Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer (NCT00054470) | The University of Texas Health Science Center at San Antonio | 2002-12-01 |
| Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer (NCT00054275) | Paula Silverman, MD | 2002-12-01 |
| Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy (NCT00036686) | H. Lee Moffitt Cancer Center and Research Institute | 2002-12-01 |
| Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer (NCT00052728) | National Cancer Institute (NCI) | 2002-12-01 |
| EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer (NCT00046891) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma (NCT00165581) | Dana-Farber Cancer Institute | 2002-12-01 |
| Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer (NCT00854789) | COL George Peoples, MD, FACS | 2002-12-01 |
| Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer (NCT00053911) | UNICANCER | 2002-11-01 |
| Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer (NCT00054301) | Case Comprehensive Cancer Center | 2002-11-01 |
| A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. (NCT00063102) | Abbott | 2002-11-01 |
| Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases (NCT00060138) | Chugai Pharmaceutical | 2002-11-01 |
| Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer (NCT00083148) | Roswell Park Cancer Institute | 2002-11-01 |
| Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer (NCT01207635) | M.D. Anderson Cancer Center | 2002-11-01 |
| Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer (NCT00075413) | The University of Texas Medical Branch, Galveston | 2002-11-01 |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer (NCT00050167) | M.D. Anderson Cancer Center | 2002-11-01 |
| Treatment for Patients Suffering From Anemia Due to Chemotherapy (NCT00120692) | Amgen | 2002-10-01 |
| Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study (NCT00595062) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer (NCT00647582) | Mayo Clinic | 2002-10-01 |
| Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer (NCT00052676) | Centre Paul Strauss | 2002-10-01 |
| Treatment for Elderly Patients With High Risk Breast Cancer (NCT00117910) | Amgen | 2002-10-01 |
| Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast (NCT00082667) | Vanderbilt-Ingram Cancer Center | 2002-10-01 |
| A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study (NCT00096967) | Genentech, Inc. | 2002-10-01 |
| Combination Chemotherapy for Metastatic Breast Cancer (NCT00191815) | Eli Lilly and Company | 2002-10-01 |
| Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer (NCT01023204) | Bristol-Myers Squibb | 2002-10-01 |
| Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer (NCT00328783) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2002-10-01 |
| Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer (NCT00096343) | University of Alabama at Birmingham | 2002-10-01 |
| Stress, Diurnal Cortisol, and Breast Cancer Survival (NCT00226967) | Stanford University | 2002-09-08 |
| BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer (NCT00049244) | R-Pharm | 2002-09-01 |
| Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer (NCT00049660) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-09-01 |
| IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer (NCT00041223) | Royal Marsden NHS Foundation Trust | 2002-09-01 |
| Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer (NCT00059943) | Memorial Sloan Kettering Cancer Center | 2002-09-01 |
| Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer (NCT00050141) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-09-01 |
| ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer (NCT00247481) | AstraZeneca | 2002-09-01 |
| Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00049062) | The University of Texas Health Science Center at San Antonio | 2002-09-01 |
| Tamoxifen Pharmacogenetics and Clinical Effects (NCT00228930) | National Institute of General Medical Sciences (NIGMS) | 2002-09-01 |
| S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer (NCT00041067) | SWOG Cancer Research Network | 2002-09-01 |
| Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer (NCT00052351) | National Cancer Institute (NCI) | 2002-09-01 |
| Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer (NCT00544765) | GBG Forschungs GmbH | 2002-09-01 |
| Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer (NCT00185744) | Stanford University | 2002-09-01 |
| Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions (NCT00130494) | Spanish Breast Cancer Research Group | 2002-08-29 |
| A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood (NCT00117442) | Amgen | 2002-08-01 |
| Combination Chemotherapy in Treating Women With Stage I Breast Cancer (NCT00055679) | UNICANCER | 2002-08-01 |
| Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery (NCT00633750) | Vanderbilt-Ingram Cancer Center | 2002-08-01 |
| Study of Ductal Lavage in Women at High Risk for Breast Cancer (NCT00429988) | University of California, San Francisco | 2002-08-01 |
| Herceptin and GM-CSF for Metastatic Breast Cancer (NCT00429104) | M.D. Anderson Cancer Center | 2002-08-01 |
| Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study (NCT00597532) | Memorial Sloan Kettering Cancer Center | 2002-08-01 |
| Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis (NCT03401034) | German Cancer Research Center | 2002-08-01 |
| A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer (NCT00089479) | Hoffmann-La Roche | 2002-08-01 |
| Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) (NCT00544232) | GBG Forschungs GmbH | 2002-08-01 |
| Collection of Blood From Patients With Cancer (NCT00034216) | National Cancer Institute (NCI) | 2002-07-16 |
| Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer (NCT00057993) | Northwestern University | 2002-07-01 |
| Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer (NCT00074152) | ETOP IBCSG Partners Foundation | 2002-07-01 |
| Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors (NCT00049608) | National Center for Complementary and Integrative Health (NCCIH) | 2002-07-01 |
| Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer (NCT00046865) | M.D. Anderson Cancer Center | 2002-07-01 |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer (NCT00277160) | Amgen | 2002-06-01 |
| Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy (NCT00540852) | University of California, Irvine | 2002-06-01 |
| Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine (NCT00294385) | Central European Cooperative Oncology Group | 2002-06-01 |
| Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer (NCT00352378) | National Cancer Center, Korea | 2002-06-01 |
| Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics (NCT02297230) | NYU Langone Health | 2002-06-01 |
| Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer (NCT00253500) | Case Comprehensive Cancer Center | 2002-06-01 |
| IBCSG Trial 22-00 Serum Substudy (NCT02393833) | ETOP IBCSG Partners Foundation | 2002-06-01 |
| Evaluating the Effectiveness and Outcomes of Silicone Breast Prosthetics (NCT00594490) | University of California, Irvine | 2002-05-24 |
| Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer (NCT00041119) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00045097) | National Cancer Institute (NCI) | 2002-05-01 |
| Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer (NCT00043017) | American College of Radiology Imaging Network | 2002-05-01 |
| Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer (NCT00047255) | Jonsson Comprehensive Cancer Center | 2002-05-01 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer (NCT01998906) | Hoffmann-La Roche | 2002-05-01 |
| Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer (NCT00429871) | Hellenic Oncology Research Group | 2002-05-01 |
| Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery (NCT00233974) | UNC Lineberger Comprehensive Cancer Center | 2002-05-01 |
| Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885) (NCT00408863) | Organon and Co | 2002-05-01 |
| Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors (NCT01831076) | University of Colorado, Denver | 2002-04-01 |
| Soy Protein and Breast Cancer Risk Reduction (NCT00204477) | The University of Texas Medical Branch, Galveston | 2002-04-01 |
| Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer (NCT00146588) | Craig A. Bunnell, MD, MPH | 2002-04-01 |
| Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions (NCT00721435) | University of Michigan | 2002-04-01 |
| A Decision Aid for Women With Early Stage Breast Cancer (NCT00201929) | Ontario Clinical Oncology Group (OCOG) | 2002-04-01 |
| Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer (NCT00431106) | Hellenic Oncology Research Group | 2002-04-01 |
| Biologic Correlative Taxotere/AC (NCT00206466) | Baylor Breast Care Center | 2002-04-01 |
| Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer (NCT00037024) | Duke University | 2002-04-01 |
| Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease (NCT00031720) | Alliance for Clinical Trials in Oncology | 2002-03-01 |
| Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients (NCT00082654) | Fred Hutchinson Cancer Center | 2002-03-01 |
| Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer (NCT00193011) | SCRI Development Innovations, LLC | 2002-03-01 |
| Percutaneous Removal and Margin Ablation for Breast Cancer (NCT00574301) | University of Arkansas | 2002-03-01 |
| Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer (NCT00191243) | Eli Lilly and Company | 2002-03-01 |
| Using Diagnostic Tools to Stage Breast Cancer (NCT00367666) | University of Pennsylvania | 2002-03-01 |